[1]
M. Chadha, R. Dhediya, G. Saxena, and S. L. Naik, “A study to assess clinical profile of Indian type 2 diabetes mellitus patients treated with Teneligliptin-ASPIRE study”, Int J Basic Clin Pharmacol, vol. 8, no. 7, pp. 1542–1546, Jun. 2019.